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Knowledge of regression to the mean can help with everything from interpreting test results to
improving your career prospects. All healthcare professionals should be aware of its implications
Regression to the mean is a widespread statistical phe-
nomenon with potentially serious implications for
health care. It can result in wrongly concluding that an
effect is due to treatment when it is due to chance.
Ignorance of the problem will lead to errors in decision
making. We discuss the importance of the issue and its
effects on many common clinical, public health, and
managerial decisions.
What is regression to the mean?
Regression to the mean occurs whenever a non-
random sample is selected from a population and two
imperfectly correlated variables are measured, such as
two consecutive blood pressure measurements. The
less correlated the two variables, the larger the effect of
regression to the mean. Also, the more extreme the
value from the population mean, the more room there
is to regress to the mean. It occurs whenever a group is
selected with extreme values for one variable and
another variable is then measured.1 2
Francis Galton documented the phenomenon in
1886. Galton measured the height of 930 adult
children and their parents and calculated the average
height of the parents. He noted that when the average
height of the parents was greater than the mean of the
population, the children tended to be shorter then the
parents. Likewise, when the average height of the par-
ents was shorter than the population mean, the
children tended to be taller than their parents. Galton
called this phenomenon regression towards medioc-
rity, and it is now known as regression to the mean.3
Ignorance of this phenomenon is widespread. Pilot
instructors noted that when a trainee pilot was praised
for a good landing they invariably made a subsequent
poor landing. This was misinterpreted as praise lulling
pilots into complacency when the real explanation was
regression towards the mean.4 All healthcare profes-
sionals need to be aware of regression to the mean as it
has wide ranging effects.
Diagnostic tests
Clinicians use diagnostic tests to target and monitor
treatment. Regression to the mean can confound this
strategy. The preliminary test has a high probability of
giving an abnormal result through chance, and initial
treatment may be unnecessary. Because of this chance
effect, there is a high probability that subsequent meas-
urements will spontaneously regress towards the mean
value. This misleads clinicians and patients into think-
ing that treatment has been effective when the
treatment was either not required or ineffective.
The figure shows the effect of regression to the mean
in women treated for osteoporosis. Some women
continue to lose bone at the first follow up measure-
ment despite effective treatment.5 It is tempting to
assume that treatment is ineffective in those women who
are losing bone. However, because of regression to the
mean, most patients ( > 80%) who lost bone in the first
year of treatment went on to gain bone in the second
year despite no change in treatment.
The solution to this problem depends on the cost
and complexity of the test. Firstly, monitoring may be
unnecessary. In the case of bone density measurements,
one solution is to forego monitoring and change a
patient’s treatment only on clinical grounds, such as
intolerance. When monitoring of treatment is less
expensive, such as measuring blood pressure, the effect
of regression to the mean can be reduced by taking
serial measurements and calculating the average
change.
A further figure
is available on
bmj.com
Summary points
Regression to the mean affects all aspects of
health care
Any intervention aimed at a group or characteristic
that is very different from the average will appear
to be successful because of regression to the mean
In clinical practice, the phenomenon can lead to
misinterpretation of results of tests, new
treatments, and the placebo effect
Public health interventions are often aimed at
sudden increases in disease and thus vulnerable
to the effects of regression to the mean
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New treatments
When new treatments become available, some
clinicians may yield to the temptation of trying out the
treatment on the patients who are most ill. This under-
standable desire to treat clinical outliers will usually
produce a gratifying and sharp response to treatment
because of regression to the mean. Furthermore, if the
relevant clinical trials excluded patients who were
resistant to treatment and clinicians use the treatment
outside the licensed conditions, they may get the
mistaken impression that the new treatment is even
better among such patients.
Placebo effect
Trials of hormone replacement therapy show a strong
placebo effect on menopausal symptoms.6 This implies
that menopausal symptoms are susceptible to placebo
treatment. However, a recent systematic review of
placebo versus “open” no treatment found little
evidence for the placebo effect.7 A more likely explana-
tion is that the placebo effect is simply regression to the
mean. Women recruited to trials of hormone
replacement therapy typically score highly on a symp-
tom index. Because the trialists are identifying women
with relatively extreme menopausal symptoms, once
treatment starts, improvement will occur in both the
placebo and active treatment groups because of
regression to the mean. An indication that regression
to the mean is occurring is that patients with the worst
clinical scores have the biggest placebo effect.
Public health
Public health interventions are often driven by
unexpected increases in incidence of disease. A classic
example is the response to a sudden rise in traffic inci-
dents. Because a sudden peak in road crashes is often
due to chance, changes in policy, such as more
rigorous enforcement of speed laws, will reduce
crashes because of regression to the mean. The policy
of vaccinating children against meningitis was intro-
duced at a time of heightened incidence (see bmj.com).
The headline benefit of a 75%-90% reduction in cases8
is an overestimate as most of the reduction would have
been due to regression to the mean.
If public health physicians wish to prove their
worth, our advice is that they focus their efforts on a
group of problems that are much worse than the
national average or have shown an unexpected
increase as there will usually be an improvement. It is
important, however, to focus on a group of outliers to
guarantee an effect because there is a chance that
regression to the mean will not affect the results of a
single outlier as it is a group phenomenon.
Healthcare management
Regression to the mean can justify league table
initiatives for improving poorly performing hospitals.
When poor hospitals are helped by allocating them
more resources, regression to the mean will ensure that
most will suddenly climb the league table. In contrast,
hospitals at the top of the league table who are
rewarded with increased resources for their efforts will
fall in the table. If governments want to justify any ini-
tiative, it is better to target those at the bottom of the
league than those at the top. For the individual hospi-
tal manager, the problem is more complex. Those who
manage the worst hospitals are likely to see an
improvement and thus enhance their careers. How-
ever, because regression to the mean is a group
phenomenon, the improvement is not certain, and
some hospitals will move in the opposite direction.
Clinical audit
An audit might identify patients that were operated on
by a particular surgical team and had unexpectedly
poor results, such as increased postoperative infec-
tions. Implementation of a policy of aggressive
procedures to control infection will again often seem
to work because of regression to the mean.
What are the solutions?
Understanding the phenomenon is a first step to
overcoming the problems caused by regression to the
mean. Whenever possible, policy should be based on
evidence from trials. The effectiveness of management
league tables, for example, could be tested by randomis-
ing poorly performing hospitals to new management or
extra resources. This would tell us which intervention
was most effective. In clinical practice, sequential testing
to get an average value,which most doctors would do for
blood pressure, is a solution for some tests.
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Percentage changes in bone mineral density among women treated with alendronate or
raloxifene after 12 and 24 months, showing regression to the mean at 24 months. Women
are grouped according to the percentage change at 12 months, and values for 24 months are
percentage change from value at 12 months
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